AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2902683 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (15 mg, intravenously)
Number of subjects: 12
Study 30626263 — intervention group
Group type: EXPERIMENTAL
Intervention: Local minocycline
Number of subjects: 50
Study 30626263 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 50
Study 27085343 — intervention group
Group type: COMPARATOR
Intervention: Individuals with BMI <30 kg/m2
Number of subjects: 82
Study 27085343 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuals with BMI ≥30 kg/m2
Number of subjects: 82
Study 27085343 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Fat Percentage (BFP)
Number of subjects: 82
Study 27085343 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Fat Mass (BFM)
Number of subjects: 82
Study 27085343 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin
Number of subjects: 82
Study 25616355 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment (2.5 years of tamoxifen followed by 2.5 years of exemestane)
Number of subjects: 2596
Study 25616355 — intervention group
Group type: COMPARATOR
Intervention: Exemestane treatment
Number of subjects: 2596
Study 22976166 — intervention group
Group type: EXPERIMENTAL
Intervention: Postures during computer use
Number of subjects: 74
Study 22976166 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrepancies in workstation setups and worker anthropometrics
Number of subjects: 74
Study 22031888 — intervention group
Group type: EXPERIMENTAL
Intervention: random noise stimulation (tRNS)
Number of subjects: 0
Study 22031888 — intervention group
Group type: EXPERIMENTAL
Intervention: direct current stimulation (tDCS)
Number of subjects: 0
Study 19226424 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg once daily for 2 years
Number of subjects: 0
Study 19226424 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily for 2 years
Number of subjects: 0
Study 16840878 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis (LRA) using 25 OCT parameters
Number of subjects: 160
Study 16840878 — intervention group
Group type: COMPARATOR
Intervention: OCT-provided parameters
Number of subjects: 160
Study 12757571 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity program (low-resistance exercises and weight-shifting activities)
Number of subjects: 38
Study 12757571 — intervention group
Group type: EXPERIMENTAL
Intervention: Education program (focused on identifying and reducing risk factors for falls)
Number of subjects: 38
Study 11018567 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose dialysis
Number of subjects: 0
Study 11018567 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose dialysis
Number of subjects: 0
Study 11018567 — intervention group
Group type: EXPERIMENTAL
Intervention: Low flux membranes
Number of subjects: 0
Study 11018567 — intervention group
Group type: EXPERIMENTAL
Intervention: High flux membranes
Number of subjects: 0
Study 9075752 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery intervention (listened to a guided imagery tape three days preoperatively; a music‐only tape during induction, during surgery, and postoperatively in the recovery room; a guided imagery tape during each of the first six postoperative days)
Number of subjects: 2
Study 9075752 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery intervention
Number of subjects: 2
Study 9075752 — intervention group
Group type: COMPARATOR
Intervention: Standard perioperative care (Control group)
Number of subjects: 2
Study 8396374 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/Tazobactam
Number of subjects: 331
Study 8396374 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin and Gentamicin
Number of subjects: 331
Study 3463575 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual V‐shaped toothbrush
Number of subjects: 22
Study 3463575 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual multitufted toothbrush
Number of subjects: 22
Study 3463575 — intervention group
Group type: COMPARATOR
Intervention: Electric toothbrush
Number of subjects: 22
Study 29158449 — intervention group
Group type: EXPERIMENTAL
Intervention: Induced hypertension
Number of subjects: 41
Study 29158449 — intervention group
Group type: COMPARATOR
Intervention: No induced hypertension
Number of subjects: 41
Study 26476151 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-valent HPV vaccine
Number of subjects: 332
Study 26476151 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study 24419017 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation to supraspinatus, posterior deltoid & long head of biceps along with routine physiotherapy and occupational therapy for 5 weeks
Number of subjects: 24
Study 24419017 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation to supraspinatus & posterior deltoid along with routine physiotherapy and occupational therapy for 5 weeks
Number of subjects: 24
Study 22284923 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin A 10,000 IU 3 times weekly from day 2 for a minimum of 2 weeks or until establishment of oral feeding
Number of subjects: 89
Study 22284923 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin A supplementation)
Number of subjects: 89
Study 20390502 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider-initiated ('opt-out') HIV counseling
Number of subjects: 0
Study 18413705 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-316,311 (400 mg twice daily)
Number of subjects: 123
Study 18413705 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (100 mg daily)
Number of subjects: 123
Study 18413705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 15312100 — intervention group
Group type: EXPERIMENTAL
Intervention: GTR/bone replacement material
Number of subjects: 124
Study 15312100 — intervention group
Group type: COMPARATOR
Intervention: Access flap alone
Number of subjects: 124
Study 10911771 — intervention group
Group type: EXPERIMENTAL
Intervention: Efacal (Ca 1.0 g, evening primrose oil 4.0 g, marine fish oil 440 mg)
Number of subjects: 85
Study 10911771 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone (Ca 1.0 g)
Number of subjects: 85
Study 10911771 — intervention group
Group type: EXPERIMENTAL
Intervention: Efacal
Number of subjects: 85
Study 10911771 — intervention group
Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 85
Study 9192063 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminosalicylates
Number of subjects: 0
Study 9192063 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 9192063 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (new topical steroid)
Number of subjects: 0
Study 9192063 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-chain fatty acids, local anaesthetics, bismuth compounds
Number of subjects: 0
Study 7506185 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (acetylsalicylic acid)
Number of subjects: 112
Study 7506185 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 112
Study 7506185 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidazole-hydroxybenzoate
Number of subjects: 112
Study 7506185 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 112
Study 3723448 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety-inducing cognitive task
Number of subjects: 0
Study 3723448 — intervention group
Group type: EXPERIMENTAL
Intervention: Velten-type depression-inducing manipulation
Number of subjects: 0
Study 31485722 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-brain stimulation (DBS) with non-rechargeable batteries
Number of subjects: 17
Study 31485722 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-brain stimulation (DBS) with rechargeable batteries
Number of subjects: 17
Study 31485722 — intervention group
Group type: COMPARATOR
Intervention: Best medical treatment (BMT)
Number of subjects: 17
Study 27888561 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 52
Study 27888561 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine (GL)
Number of subjects: 52
Study 27054797 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD) using BladderTrakHer Web app
Number of subjects: 122
Study 27054797 — intervention group
Group type: COMPARATOR
Intervention: Paper voiding diary (PVD)
Number of subjects: 122
Study 27054797 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD)
Number of subjects: 122
Study 27054797 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD) and Paper voiding diary (PVD)
Number of subjects: 122
Study 24378283 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-IFN + RBV
Number of subjects: 176
Study 22449810 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement (GIC)
Number of subjects: 173
Study 22449810 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-based fissure sealant
Number of subjects: 173
Study 19540640 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, 10 mg/d
Number of subjects: 2838
Study 17560731 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained men (elite sportsmen)
Number of subjects: 44
Study 17560731 — intervention group
Group type: COMPARATOR
Intervention: Untrained men
Number of subjects: 44
Study 15446651 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS) ratings for musculoskeletal fatigue after applying external loads at 0, 5, 10, 15, 25, 35, and 50% of maximum voluntary contraction.
Number of subjects: 20
Study 15446651 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher external loads (25‐50% maximum load)
Number of subjects: 20
Study 15446651 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower external loads (0‐15% maximum load)
Number of subjects: 20
Study 10858380 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 208
Study 10858380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 9040258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory care curriculum (3-week component including evaluation of walk-in patients, exposure to community internists, and a lecture series)
Number of subjects: 196
Study 9040258 — intervention group
Group type: COMPARATOR
Intervention: Traditional curriculum (exclusively inpatient)
Number of subjects: 196
Study 8457023 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 micrograms sodium selenite daily for 14 weeks)
Number of subjects: 24
Study 8457023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3510704 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical stapling with a GIA/TA instrument (43 patients)
Number of subjects: 88
Study 3510704 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-layer hand suturing (45 patients)
Number of subjects: 88
Study 3510704 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical stapling (43 patients)
Number of subjects: 88
Study 3510704 — intervention group
Group type: COMPARATOR
Intervention: Conventional suturing (45 patients)
Number of subjects: 88
Study 3510704 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 31082538 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ablation (SA)
Number of subjects: 207
Study 31082538 — intervention group
Group type: COMPARATOR
Intervention: Control (no ablation)
Number of subjects: 207
Study 29737274 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring
Number of subjects: 263
Study 29737274 — intervention group
Group type: COMPARATOR
Intervention: Clinical features monitoring
Number of subjects: 263
Study 27157953 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing (three times a day)
Number of subjects: 60
Study 27157953 — intervention group
Group type: COMPARATOR
Intervention: Control (no gum chewing)
Number of subjects: 60
Study 26276914 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of depression during 6 months after myocardial infarction
Number of subjects: 44
Study 26276914 — intervention group
Group type: COMPARATOR
Intervention: No depression during 6 months after myocardial infarction
Number of subjects: 44
Study 24108261 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 44
Study 24108261 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 44
Study 24108261 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 21368663 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (BT)
Number of subjects: 61
Study 21368663 — intervention group
Group type: COMPARATOR
Intervention: Trimacinolone injection (TA)
Number of subjects: 61
Study 18199130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day for 4 weeks
Number of subjects: 20
Study 18199130 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day for 4 days followed by placebo for 3 weeks
Number of subjects: 20
Study 18199130 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic sildenafil administration
Number of subjects: 20
Study 18199130 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16618044 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 16618044 — intervention group
Group type: COMPARATOR
Intervention: Control procedures (minimal, superficial, sham acupuncture)
Number of subjects: 0
Study 14662284 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin-mineral supplement containing recommended daily allowance (RDA) dosages
Number of subjects: 0
Study 14662284 — intervention group
Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 0
Study 11894282 — intervention group
Group type: EXPERIMENTAL
Intervention: Metamucil
Number of subjects: 60
Study 11894282 — intervention group
Group type: COMPARATOR
Intervention: Control (no Metamucil)
Number of subjects: 60
Study 8922504 — intervention group
Group type: EXPERIMENTAL
Intervention: Geristore (resin modified glass ionomer cement)
Number of subjects: 40
Study 8922504 — intervention group
Group type: COMPARATOR
Intervention: Phase II (composite resin)
Number of subjects: 40
Study 8922504 — intervention group
Group type: EXPERIMENTAL
Intervention: Geristore
Number of subjects: 40
Study 8922504 — intervention group
Group type: COMPARATOR
Intervention: Phase II
Number of subjects: 40
Study 1395760 — intervention group
Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 8
Study 1395760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 30888691 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.2 mg
Number of subjects: 300
Study 30888691 — intervention group
Group type: COMPARATOR
Intervention: Tolterodine 4 mg
Number of subjects: 300
Study 28257107 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified milk
Number of subjects: 296
Study 28257107 — intervention group
Group type: COMPARATOR
Intervention: Unfortified milk
Number of subjects: 296
Study 26108207 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home program (2-week telephone outreach initiative)
Number of subjects: 180
Study 26108207 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 180
Study 26108207 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home program
Number of subjects: 180
Study 24314835 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemianopia
Number of subjects: 30
Study 24314835 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrantanopia
Number of subjects: 30
Study 24314835 — intervention group
Group type: EXPERIMENTAL
Intervention: Central scotoma
Number of subjects: 30
Study 24314835 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability measures
Number of subjects: 30
Study 22524831 — intervention group
Group type: COMPARATOR
Intervention: HPV16 single infection
Number of subjects: 8
Study 22524831 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV16 multiple infection
Number of subjects: 8
Study 19651872 — intervention group
Group type: EXPERIMENTAL
Intervention: RTS,S/AS02D malaria vaccine candidate
Number of subjects: 0
Study 19651872 — intervention group
Group type: COMPARATOR
Intervention: Comparator vaccine
Number of subjects: 0
Study 18804274 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 3298
Study 15319311 — intervention group
Group type: EXPERIMENTAL
Intervention: Imitation tasks using photographs of hand postures or symbolic specification of the postures
Number of subjects: 0
Study 15319311 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed execution tasks
Number of subjects: 0
Study 15319311 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI)
Number of subjects: 0
Study 12241657 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg rifapentine plus 900 mg isoniazid once a week
Number of subjects: 1004
Study 12241657 — intervention group
Group type: COMPARATOR
Intervention: 600 mg rifampicin plus 900 mg isoniazid twice a week
Number of subjects: 1004
Study 12241657 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg rifapentine plus 900 mg isoniazid once a week (without cavitation)
Number of subjects: 1004
Study 12241657 — intervention group
Group type: COMPARATOR
Intervention: 600 mg rifampicin plus 900 mg isoniazid twice a week (without cavitation)
Number of subjects: 1004
Study 12241657 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 1004
Study 9973585 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-massage treatment
Number of subjects: 20
Study 9973585 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 7549378 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Ginseng
Number of subjects: 45
Study 7549378 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Ginseng plus digoxin
Number of subjects: 45
Study 7549378 — intervention group
Group type: COMPARATOR
Intervention: digoxin
Number of subjects: 45
Study 2142731 — intervention group
Group type: EXPERIMENTAL
Intervention: Naprosyn 500 mg b.i.d. for 30 days
Number of subjects: 114
Study 2142731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study 6254602 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula, Motival, and Mebeverine
Number of subjects: 96
Study 6254602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine with Motival
Number of subjects: 96
Study 6254602 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebeverine with Lorazepam
Number of subjects: 96
Study 6254602 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula
Number of subjects: 96
Study 6254602 — intervention group
Group type: COMPARATOR
Intervention: Bran, Motival, and Hyoscine
Number of subjects: 96
Study 6254602 — intervention group
Group type: COMPARATOR
Intervention: Bran, Lorazepam, and Mebeverine
Number of subjects: 96
Study 6254602 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of agents
Number of subjects: 96
Study 30848098 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-fantasy cartoons
Number of subjects: 143
Study 30848098 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fantasy cartoons
Number of subjects: 143
Study 30848098 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fantasy cartoons
Number of subjects: 143
Study 30848098 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory tasks
Number of subjects: 143
Study 25172884 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (Mindful Family Stress Reduction)
Number of subjects: 41
Study 25172884 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 41
Study 25871017 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame seed supplementation (40 g daily for 2 months)
Number of subjects: 50
Study 25871017 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 g placebo powder daily for 2 months)
Number of subjects: 50
Study 25871017 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Sesame and Control)
Number of subjects: 50
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick tests for allergens
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Grass mix
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Olea European
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Dust mites mix
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Cypress
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Parietaria officinalis
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Cat dander
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog dander
Number of subjects: 497
Study 23866689 — intervention group
Group type: EXPERIMENTAL
Intervention: Altenaria
Number of subjects: 497
Study 21142752 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 20
Study 19480651 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous theta-burst stimulation (cTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20
Study 19480651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20
Study 19480651 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate theta-burst stimulation (imTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20
Study 19480651 — intervention group
Group type: COMPARATOR
Intervention: Responder group
Number of subjects: 20
Study 19480651 — intervention group
Group type: COMPARATOR
Intervention: Non-responder group
Number of subjects: 20
Study 17363193 — intervention group
Group type: EXPERIMENTAL
Intervention: Injecting alone (n=467)
Number of subjects: 3199
Study 17363193 — intervention group
Group type: COMPARATOR
Intervention: Other IDUs (control group)
Number of subjects: 3199
Study 14707555 — intervention group
Group type: EXPERIMENTAL
Intervention: 546C88
Number of subjects: 312